uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Activity of hydrolytic enzymes in tumour cells is a determinant for anti-tumour efficacy of the melphalan containing prodrug J1.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Cancer Pharmacology and Informatics)
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Cancer Pharmacology and Informatics)
Show others and affiliations
2003 (English)In: J Drug Target., Vol. 11, 355- p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2003. Vol. 11, 355- p.
Identifiers
URN: urn:nbn:se:uu:diva-65414OAI: oai:DiVA.org:uu-65414DiVA: diva2:93325
Available from: 2007-02-08 Created: 2007-02-08 Last updated: 2011-01-13

Open Access in DiVA

No full text

Authority records BETA

Gullbo, JoachimWickström, MalinNygren, PeterLarsson, Rolf

Search in DiVA

By author/editor
Gullbo, JoachimWickström, MalinNygren, PeterLarsson, Rolf
By organisation
Department of Medical SciencesDepartment of Oncology, Radiology and Clinical Immunology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 581 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf